These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2102483)

  • 1. Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice.
    Ahmad I; Sarkar AK; Bachhawat BK
    Indian J Biochem Biophys; 1990 Dec; 27(6):370-4. PubMed ID: 2102483
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomal amphotericin-B in the control of experimental aspergillosis in mice: Part I--Relative therapeutic efficacy of free and liposomal amphotericin-B.
    Ahmad I; Sarkar AK; Bachhawat BK
    Indian J Biochem Biophys; 1989 Dec; 26(6):351-6. PubMed ID: 2698855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amphotericin B in three lung transplant recipients. The Groningen Lung Transplantation Group.
    Mannes GP; van der Bij W; de Boer WJ
    J Heart Lung Transplant; 1995; 14(4):781-4. PubMed ID: 7578189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An experimental study of the therapeutic effect of interleukin-2 and interleukin-12 with and without amphotericin B on pulmonary fungal infection].
    Zhang CR; Tang YC; Kawakami K; Zhang TT; Zhang KX; Zhu JX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):234-6. PubMed ID: 15144612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient.
    Katz NM; Pierce PF; Anzeck RA; Visner MS; Canter HG; Foegh ML; Pearle DL; Tracy C; Rahman A
    J Heart Transplant; 1990; 9(1):14-7. PubMed ID: 2313415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
    Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of experimental invasive pulmonary aspergillosis in rats with liposomal amphotericin B].
    Matsuda H; Kohno S; Miyazaki Y; Mitsutake K; Tanaka K; Maesaki S; Iwamoto M; Hashimoto A; Kaku M; Koga H
    Kansenshogaku Zasshi; 1993 Feb; 67(2):102-9. PubMed ID: 8468494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of liposome encapsulated amphotericin to treat invasive aspergillosis following failure of conventional amphotericin.
    Richards EM; Apperley JF; Marcus RE
    Clin Lab Haematol; 1992; 14(2):127-30. PubMed ID: 1633682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK; Cutright JL; Chandrasekar PH
    Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug combinations in the treatment of invasive aspergillosis].
    Esposito R; Lazzarin A; Rossi E
    G Ital Chemioter; 1984; 31(1-2):169-72. PubMed ID: 6381204
    [No Abstract]   [Full Text] [Related]  

  • 12. A non-immunosuppressed patient with presumably invasive pulmonary aspergillosis and a favourable outcome.
    Schrijver G; Verwers HR; Meinders AE
    Neth J Med; 1983; 26(4):112-9. PubMed ID: 6343901
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of liposomes to improve delivery of amphotericin-B in the treatment of aspergillosis.
    Ahmad I; Sarkar AK; Bachhawat BK
    Mol Cell Biochem; 1989 Nov 23-Dec 19; 91(1-2):85-90. PubMed ID: 2695834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholesterol in various liposomal compositions on the in vivo toxicity, therapeutic efficacy, and tissue distribution of amphotericin B.
    Ahmad I; Sarkar AK; Bachhawat BK
    Biotechnol Appl Biochem; 1990 Oct; 12(5):550-6. PubMed ID: 2288711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal hamycin in the control of experimental aspergillosis in mice: relative toxicity, therapeutic efficacy and tissue distribution of free and liposomal hamycin.
    Moonis M; Ahmad I; Bachhawat BK
    Indian J Biochem Biophys; 1992 Aug; 29(4):339-45. PubMed ID: 1427960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
    Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
    Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis.
    Owais M; Ahmed I; Krishnakumar B; Jain RK; Bachhawat BK; Gupta CM
    FEBS Lett; 1993 Jul; 326(1-3):56-8. PubMed ID: 8325389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight.
    Lackner H; Schwinger W; Urban C; Müller W; Ritschel E; Reiterer F; Kuttnig-Haim M; Urlesberger B; Hauer C
    Pediatrics; 1992 Jun; 89(6 Pt 2):1259-61. PubMed ID: 1594386
    [No Abstract]   [Full Text] [Related]  

  • 19. Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
    Ruijgrok EJ; Fens MH; Bakker-Woudenberg IA; van Etten EW; Vulto AG
    Antimicrob Agents Chemother; 2006 May; 50(5):1852-4. PubMed ID: 16641459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B.
    Khan MA; Ahmad N; Moin S; Mannan A; Wajahul H; Pasha ST; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):269-76. PubMed ID: 15907448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.